A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study.
Sim HW, McDonald KL, Lwin Z, Barnes EH, Rosenthal M, Foote MC, Koh ES, Back M, Wheeler H, Sulman EP, Buckland ME, Fisher L, Leonard R, Hall M, Ashley DM, Yip S, Simes J, Khasraw M.
Sim HW, et al. Among authors: mcdonald kl.
Neuro Oncol. 2021 Oct 1;23(10):1736-1749. doi: 10.1093/neuonc/noab111.
Neuro Oncol. 2021.
PMID: 33984151
Free PMC article.
Clinical Trial.